Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Alvogen Issues Voluntary Nationwide Recall of Clindamycin Injection Due to a Potential for a Lack of

americanpharmaceuticalreviewJune 22, 2017

Tag: recall , Alvogen , Clindamycin Injection

PharmaSources Customer Service